DERIVES D'UREE 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL ET LEUR UTILISATION DANS LE TRAITEMENT, ENTRE AUTRES, DE MALADIES DES VOIES RESPIRATOIRATOIRES
Disclosed are compounds having [1,2,4]triazolo[4,3-a] pyridine groups and pharmaceutically acceptable salts thereof. The compounds are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.